Geron and GE
Screening new drugs with stem cells. Industry collaboration in the field was presented as essential; a collaboration with Geron proved to be critical in advancing GE Healthcare's toxicology work. "What we gained from Geron's is the ability to grow large quantities of cells on an industrial scale. One of the first products that we created in collabration with Geron was cardiomyocyte generation from h7hES cells. It ended up being a 28 , day process of selection with no genetic engineering.
The cost savings for drug development are substantial as stem cells can be used to expose drugs with dangerous side effects before they reach the market.
So while stem cells still hold great promise for regenerative medicine their use as tools for research and drug testing is having more immediate impact.
Show me the money GE! When will Geron get more payments. Geron will not disclose details of payments if any. Geron hit a new 52 week low again at $1.25.
Good luck in this rigged casino,
No comments:
Post a Comment